Opioid Special Master's Email Doesn't Betray Bias, Court Told

By Theresa Schliep · September 28, 2023, 8:06 PM EDT

The plaintiffs' executive committee in multidistrict opioid litigation against pharmacy benefit managers OptumRX Inc. and Express Scripts Inc. has urged an Ohio federal court to reject their bid to disqualify the...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opposition

Case Information

Case Title

In Re: National Prescription Opiate Litigation

Case Number

Court

Ohio Northern

Nature of Suit

P.I.: Other

Date Filed

November 04, 2022

Recent Articles By Theresa

July 02, 2024
4 Takeaways From FDA's Clinical Trial Diversity Guidance
June 28, 2024
Health Regulators Likely To Tread Carefully Post-Chevron
June 25, 2024
Mich. Judge Blocks State Abortion Waiting Period, Counseling
June 25, 2024
In High Court Loss, Anti-Abortion Atty Sees Win For Objectors
June 18, 2024
Prelogar's Mifepristone Win Is 'A Master Class,' Advocates Say
June 13, 2024
Abortion Medication Case Ends 'With A Whimper' At High Court
June 04, 2024
HHS Guidance, Feud Over FCA Evidence, And A Deposed AG
June 04, 2024
What Clinical Trial Attys Want From FDA Diversity Guidance
May 31, 2024
15 States Sue To Block Biden's ACA Trans Discrimination Rule
May 28, 2024
More States Look To Rx Boards To Tackle Drug Prices